Enzo Biochem Inc's ability to collect accounts receivable sequentially worsen to 6.71, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Enzo Biochem Inc's Accounts Receivable average collection period in the Apr 30 2025 quarter, has increased to 54 days, from 50 days, in the Jan 31 2025 quarter.

If we take a look into Healthcare sector 270 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2016, from overall ranking in the second quarter 2025 at 2557.

What is Receivable Turnover Ratio?
What is Enzo Biochem Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ENZ Receivables Turnover Ratio	(Apr 30 2025) III. Quarter	(Jan 31 2025) II. Quarter	(Oct 31 2024) I. Quarter	(Jul 31 2024) IV. Quarter	(Apr 30 2024) III. Quarter
Y / Y Receivable Change	9.5 %	-17.03 %	-8.11 %	-17.05 %	-59.16 %
Y / Y Revenue Change	-20.19 %	-14.25 %	-20.41 %	-	7.17 %
Receivable Turnover Ratio (TTM)	6.71	7.27	7.18	7.41	1.05
ENZ's Total Ranking	# 2016	# 2557	# 0	#	#
Accounts Receivable average collection period days	54	50	51	49	349
Seq. Receivable Change	1.51 %	10.49 %	-3.66 %	1.35 %	-23.08 %
Seq. Revenue Change	-12.71 %	18.04 %	-17.45 %	-6.18 %	-6.21 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 26
Healthcare Sector	# 271
Overall Market	# 2016

Receivable Turnover Ratio Statistics
High	Average	Low
10.28	7.23	0.27
(Jul 31 2021)		(Jul 31 2023)

ENZ Company Profile • Back to ENZ Efficiency Comparisons • Compare ENZ Receivables Turnover Ratio to its Competitors

Financial Statements
Enzo Biochem Inc's Accounts Receivable	$ 4 Millions	Visit ENZ's Balance sheet
Enzo Biochem Inc's Sales TTM	$ 27 Millions	Visit ENZ's Income Statement
Sources of ENZ's Revenues		Visit ENZ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ENZ's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ENZ's Growth Rates	ENZ's Roa	ENZ's Inventory Turnover Ratio	ENZ's Dividend Comparisons
ENZ's Profitability Ratios	ENZ's Roi	ENZ's Asset Turnover Ratio	ENZ's Dividend Growth
ENZ's Valuation Ratios	ENZ's Roe	ENZ's Financial Strength Ratios	ENZ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 30 2025	Receivable at quarter ending Apr 30 2025
Milestone Scientific Inc	17.43	$ 8.418 Millions	$ 0.483 Millions
Innoviva Inc	17.30	$ 408.353 Millions	$ 23.598 Millions
Neuraxis Inc	17.06	$ 2.935 Millions	$ 0.172 Millions
Novavax inc	17.00	$ 1,254.962 Millions	$ 73.803 Millions
Bellevue Life Sciences Acquisition Corp	16.92	$ 3.381 Millions	$ 0.200 Millions
Pluri Inc	16.81	$ 1.034 Millions	$ 0.062 Millions
Generation Bio Co	15.93	$ 24.556 Millions	$ 1.541 Millions
Petvivo Holdings Inc	15.90	$ 1.133 Millions	$ 0.071 Millions
Zomedica Corp	15.35	$ 27.377 Millions	$ 1.783 Millions
Scienture Holdings Inc	15.32	$ 0.147 Millions	$ 0.010 Millions
Ontrak Inc	15.28	$ 9.890 Millions	$ 0.647 Millions
Quipt Home Medical Corp	15.17	$ 425.431 Millions	$ 28.053 Millions
Kiniksa Pharmaceuticals International Plc	15.14	$ 481.166 Millions	$ 31.782 Millions
China Pharma Holdings Inc	14.95	$ 4.295 Millions	$ 0.287 Millions
Mannkind Corporation	14.48	$ 297.595 Millions	$ 20.559 Millions
Icu Medical Inc	14.25	$ 2,419.911 Millions	$ 169.876 Millions
Inmed Pharmaceuticals Inc	14.25	$ 4.515 Millions	$ 0.317 Millions
Co diagnostics Inc	14.01	$ 3.498 Millions	$ 0.250 Millions
Absci Corp	13.92	$ 4.815 Millions	$ 0.346 Millions
Lipella Pharmaceuticals Inc	13.76	$ 0.520 Millions	$ 0.038 Millions
Biofrontera Inc	13.45	$ 59.599 Millions	$ 4.431 Millions
Dyadic International Inc	13.39	$ 3.554 Millions	$ 0.265 Millions
Lftd Partners Inc	13.23	$ 35.782 Millions	$ 2.704 Millions
Grail Inc	13.17	$ 130.711 Millions	$ 9.925 Millions
Rosecliff Acquisition Corp I	13.04	$ 29.581 Millions	$ 2.268 Millions
Day One Biopharmaceuticals Inc	13.02	$ 161.922 Millions	$ 12.440 Millions
Ptc Therapeutics inc	12.99	$ 1,772.758 Millions	$ 136.420 Millions
Nrc Health	12.99	$ 141.298 Millions	$ 10.874 Millions
Voyager Therapeutics Inc	12.89	$ 66.958 Millions	$ 5.196 Millions
Qhslab Inc	12.70	$ 2.289 Millions	$ 0.180 Millions

Date modified: 2026-09-08T17:35:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.